23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-38.56%
Negative revenue growth while Insurance - Life median is -0.39%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-38.56%
Negative gross profit growth while Insurance - Life median is -0.33%. Seth Klarman would suspect poor product pricing or inefficient production.
-51.14%
Negative EBIT growth while Insurance - Life median is -12.84%. Seth Klarman would check if external or internal factors caused the decline.
-51.14%
Negative operating income growth while Insurance - Life median is -24.40%. Seth Klarman would check if structural or cyclical issues are at play.
-51.27%
Negative net income growth while Insurance - Life median is -23.97%. Seth Klarman would investigate factors dragging net income down.
-51.28%
Negative EPS growth while Insurance - Life median is -20.70%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-51.28%
Negative diluted EPS growth while Insurance - Life median is -20.75%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.85%
OCF growth 75-90% of Insurance - Life median of 24.27%. John Neff would push for improvements in working capital or margins.
19.85%
FCF growth near Insurance - Life median of 19.85%. Charlie Munger could consider this standard for the industry’s capex cycle.
-33.77%
Negative 10Y revenue/share CAGR while Insurance - Life median is 39.80%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
10.44%
Below 50% of Insurance - Life median. Jim Chanos would suspect structural disadvantages or a higher share base limiting per-share growth.
103.22%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 41.23%. Joel Greenblatt might see a short-term competitive advantage at play.
382.27%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 86.32% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
30.27%
5Y OCF/share growth 50-75% of Insurance - Life median. Guy Spier would worry about a persistent shortfall vs. peers.
21.02%
3Y OCF/share growth 75-90% of Insurance - Life median. John Neff would seek operational tweaks to match peers’ recent gains.
199.14%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 78.23% over a decade. Joel Greenblatt might see a standout compounder of earnings.
12.04%
Below 50% of Insurance - Life median. Jim Chanos would suspect deeper problems limiting mid-term profit potential.
-30.52%
Negative 3Y CAGR while Insurance - Life median is 31.54%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
119.84%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 64.83% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
27.48%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
22.36%
Below 50% of Insurance - Life median. Jim Chanos worries about inadequate short-term profitability or repeated asset impairments.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.36%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
2.18%
Asset growth exceeding 1.5x Insurance - Life median of 0.33%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
3.13%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
1.58%
Debt growth of 1.58% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
0.63%
SG&A growth of 0.63% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.